MedTrace Logo

Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

NCT00409240 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2014-04-11

Study results available
· View outcomes & findings →

Summary

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Conditions

Interventions

OTHER

MEDIC

Multidisciplinary Education and Diabetes Intervention for Cardiac risk reduction (MEDIC; a pharmacist-led behavioral and pharmacologic intervention in groups.

Sponsors & Collaborators

  • Sandra A. Daugherty Foundation

    collaborator OTHER

  • Providence VA Medical Center

    lead FED

Principal Investigators

  • Wen-Chih Wu, MD · Providence VAMC, Brown Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00409240 on ClinicalTrials.gov